glycyl-arginyl-glycyl-aspartyl-serine has been researched along with Cranial Nerve II Injuries in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Bähr, M; Choi, BK; D'Onofrio, PM; Koeberle, PD; Shabanzadeh, AP | 1 |
1 other study(ies) available for glycyl-arginyl-glycyl-aspartyl-serine and Cranial Nerve II Injuries
Article | Year |
---|---|
MMP Inhibition Preserves Integrin Ligation and FAK Activation to Induce Survival and Regeneration in RGCs Following Optic Nerve Damage.
Topics: Animals; Blotting, Western; Cell Count; Cell Survival; Extracellular Matrix; Female; Focal Adhesion Protein-Tyrosine Kinases; Immunohistochemistry; Integrin beta1; Matrix Metalloproteinase Inhibitors; Matrix Metalloproteinases; Microscopy, Confocal; Microscopy, Fluorescence; Nerve Crush; Oligopeptides; Optic Nerve Injuries; Phosphorylation; Rats; Rats, Sprague-Dawley; Regeneration; Retinal Ganglion Cells | 2019 |